TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer
NCT00765011
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
94
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
TPF, radiotherapy and cetuximab
PROCEDURE:
H&N surgery
Sponsor
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello